# Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.

> **NCT01964989** · PHASE3 · COMPLETED · sponsor: **Seqirus** · enrollment: 10644 (actual)

## Conditions studied

- Influenza Virus

## Interventions

- **BIOLOGICAL:** Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)
- **BIOLOGICAL:** Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV)

## Key facts

- **NCT ID:** NCT01964989
- **Lead sponsor:** Seqirus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2015-10
- **Final completion:** 2016-08
- **Target enrollment:** 10644 (ACTUAL)
- **Last updated:** 2023-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01964989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01964989, "Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01964989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*